TechNavio's analysts forecast the Global Stem Anticancer Therapeutics market to grow at a CAGR of 11.48 percent over the period 2012-2016. Increasing investment in R&D is one of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval processes could pose a challenge to the growth of this market.... Research Beam Model: Research Beam Product ID: 16894 2000 USD New
Global Stem Cell Anticancer Therapeutics Market 2012-2016
 

Global Stem Cell Anticancer Therapeutics Market 2012-2016

Global Stem Cell Anticancer Therapeutics Market 2012-2016

Category : Diagnostic and Biotech

request-discount
TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Stem Anticancer Therapeutics market to grow at a CAGR of 11.48 percent over the period 2012-2016. Increasing investment in R&D is one of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval processes could pose a challenge to the growth of this market. 
TechNavio's report, the Global Stem Anticancer Therapeutics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Stem Anticancer Therapeutics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Celgene Corp., Curis Inc., Exelixis Inc., Gamida Cell Ltd., Lonza Group, Merck & Co. Inc., OncoMed Pharmaceuticals Inc., Pfizer Inc., Roche Holding AG, Teva Pharmaceutical Industries Ltd., and Verastem Inc.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

 

 

01. Executive Summary

02. List of Abbreviations

03. Introduction

04. Market Research Methodology


Market Research Process

Research Design

Research Methodology

05. Scope of the Report

Market Overview

06. Stem Cells

06.1 Autologous Cell Therapy

06.2 Allogenic Cell Therapy

07. Market Landscape

07.1 Global Stem Cell Anticancer Therapeutics Market

Market Size and Forecast

07.2 Stem Cell Anticancer Therapeutics Market in the North America

Market Size and Forecast

07.3 Stem Cell Anticancer Therapeutics Market in the Latin and South America

Market Size and Forecast

07.4 Stem Cell Anticancer Therapeutics Market in Europe

Market Size and Forecast

07.5 Stem Cell Anticancer Therapeutics Market in Asia

Market Size and Forecast

07.6 Five Forces Analysis

08. Geographical Segmentation

09. Vendor Landscape

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Key Vendor Analysis


16.1 Roche Holding AG

Business Overview

Key Information

SWOT Analysis

16.2 OncoMed Pharmaceuticals Inc.

Business Overview

Key Information

SWOT Analysis

16.3 Celgene Corp.

Business Overview

Key Information

SWOT Analysis

16.4 Merck and Co. Inc.

Business Overview

Key Information

SWOT Analysis

17. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Stem Cell Anticancer Therapeutics Market Segmentation

Exhibit 3: Global Stem Cell Anticancer Therapeutics Market 2012-2016 (US$ million)

Exhibit 4: Stem Cell Anticancer Therapeutics Market in the North America 2012-2016 (US$ million)

Exhibit 5: Stem Cell Anticancer Therapeutics Market in the Latin and South America 2012-2016 (US$ million)

Exhibit 6: Stem Cell Anticancer Therapeutics Market in Europe 2012-2016 (US$ million)

Exhibit 7: Stem Cell Anticancer Therapeutics Market in Asia 2012-2016 (US$ million)

Exhibit 8: Global Stem Cell Anticancer Therapeutics Market by Geographical Segmentation 2012

Exhibit 9: Business Segmentation of Roche Holding Ltd.

Exhibit 10: Business Segmentation of Merck & Co. Inc.



 



Enquiry Before Buy